| 000 | 00928 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250514192921.0 | ||
| 264 | 0 | _c20040728 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-200404000-00026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDonnelly, James G | |
| 245 | 0 | 0 |
_aPharmacogenetics in cancer chemotherapy: balancing toxicity and response. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cApr 2004 |
||
| 300 |
_a231-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPharmacogenetics |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 26 _gno. 2 _gp. 231-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-200404000-00026 _zAvailable from publisher's website |
| 999 |
_c14932691 _d14932691 |
||